Clinitech Laboratory IPO
IPO Details
- Open Date
25 Jul 2024
- Close Date
29 Jul 2024
- IPO Price Range
₹ 96
- IPO Size
₹ 5.78 Cr
- Listing Exchange
BSE SME
- Listing Date
01 Aug 2024
IPO Timeline
Clinitech Laboratory IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 25-Jul-2024 | - | 0.62 | 4.33 | 2.61 |
| 26-Jul-2024 | - | 1.33 | 10.10 | 6.03 |
| 29-Jul-2024 | - | 23.28 | 49.61 | 38.96 |
Last Updated: 29 July 2024 6:00 PM by 5Paisa
Last Updated: 29th July 2024, 05:50 PM by 5paisa
Clinitech Laboratory IPO is set to open on 25 July 2024 and will close on 29 July 2024. The company runs 8 diagnostic centers in and around Thane and Navi Mumbai.
The IPO includes a fresh issue of 6,02,400 shares aggregating up to ₹5.78 Cr. The price is ₹96 per share and the lot size is 1200 shares.
The allotment is scheduled to be finalized on 30 July 2024. It will go public on BSE SME, with a tentative listing date of 1 August 2024.
First Overseas Capital Limited is the book-running lead manager, while Bigshare Services Pvt Ltd is the registrar.
Objectives Of Clinitech Laboratory IPO
1. Expansion of Diagnostic Business
2. Issue Related Expenses
3. General Corporate Purposes.
Clinitech Laboratory IPO Size
| Types | Size (₹Cr) |
|---|---|
| Total IPO size | 5.78 |
| Offer for sale | - |
| Fresh issue | 5.78 |
Clinitech Laboratory IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹115200 |
| Retail (Max) | 1 | 1200 | ₹115200 |
| S-HNI (Min) | 2 | 2400 | ₹230400 |
Clinitech Laboratory IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.) |
|---|---|---|---|---|
| NII (HNI) | 23.28 | 3,01,200 | 70,12,800 | 67.32 |
| Retail | 49.61 | 3,01,200 | 1,49,41,200 | 143.44 |
| Total | 38.96 | 5,71,200 | 2,22,55,200 | 213.65 |
Clinitech Laboratory Limited, established in 1990, runs eight diagnostic centers in and around Thane and Navi Mumbai, providing diagnostic and healthcare tests and services.
The organization conducts over 300,000 tests each year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) approved labs, which are outfitted with cutting-edge technology and high-end equipment.
The company's medical testing facilities in Airoli, Navi Mumbai, have been issued a Certificate of Accreditation by the NABL (National Accreditation Board for Testing and Calibration Laboratories) under ISO 15189:2012.
As of December 31, 2023, the firm employed 74 workers across several divisions.
Peers
Dr Lalpath Lab
Thyrocare
For more information
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 6.36 | 6.46 | 4.60 |
| EBITDA | 1.37 | 1.14 | 0.87 |
| PAT | 0.61 | 0.51 | 0.40 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Total Assets | 6.03 | 3.69 | 2.73 |
| Share Capital | 1.50 | 1.50 | 0.67 |
| Total Borrowings | 1.03 | 0.89 | 0.54 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | 1.25 | 0.96 | 0.38 |
| Net cash from / (used in) investing activities | -0.65 | -1.47 | 0.54 |
| Net cash flow from / (used in) financing activities | 0.09 | 0.29 | -0.88 |
| Net increase (decrease) in cash and cash equivalents | 0.68 | -0.22 | 0.04 |
Strengths
1. Clinitech Laboratory Limited has over three decades of experience in the diagnostic and healthcare services sector.
2. The company's labs are accredited by NABL, conforming to ISO 15189:2012 standards.
3. Clinitech's diagnostic centers are equipped with modern technology and high-end equipment
Risks
1. The company operates primarily in Thane and Navi Mumbai.
2. The healthcare and diagnostic sector is subject to stringent regulatory requirements.
3. The diagnostic and healthcare services market is highly competitive.
4. The company’s operations involve significant logistical and operational challenges.
in 3
easy steps
Using 5paisa App or
Website
to block Payment
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Clinitech Laboratory IPO opens from 25th July to 29th July 2024.
The size of Clinitech Laboratory IPO is ₹5.78 Cr.
The price of Clinitech Laboratory IPO is fixed at ₹96 per share.
To apply for Clinitech Laboratory IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Clinitech Laboratory IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Clinitech Laboratory IPO is 1200 shares and the investment required is ₹1,15,200.
The share allotment date of Clinitech Laboratory IPO is 30th July 2024
The Clinitech Laboratory IPO will be listed on 1st August 2024.
First Overseas Capital Limited is the book-running lead manager for Clinitech Laboratory IPO.
Clinitech Laboratory plans to utilize the raised capital from the IPO for:
Expansion of Diagnostic Business
Issue Related Expenses
General Corporate Purposes.
Contact Information
Clinitech Laboratory
Clinitech Laboratory Limited
AL-1/545, Sector 16, Airoli
Opposite Radhikabai Meghe Vidyalaya
Navi Mumbai, Thane - 400708,
Phone: +91 22 27792281
Email: ipo@clinitechlab.com
Website: https://clinitechlab.com/
Clinitech Laboratory IPO Register
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Clinitech Laboratory IPO Lead Manager
First Overseas Capital Limited
